ProCE Banner Activity

The Future of PrEP: Shifting from a Therapeutic to a Preventive Paradigm

Clinical Thought

Widespread adoption of PrEP has great potential to reduce new HIV acquisitions and further epidemic control, so why is PrEP use still so limited? Learn about potential barriers to PrEP and how next-generation PrEP modalities can address these challenges.

Released: November 28, 2023

Share

Faculty

Linda-Gail Bekker

Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD

CEO, Desmond Tutu Health Foundation
Director, Desmond Tutu HIV Centre
Professor of Medicine
Faculty of Health Sciences
University of Cape Town
Cape Town, South Africa

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Disclosure

Primary Author

Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD

CEO, Desmond Tutu Health Foundation
Director, Desmond Tutu HIV Centre
Professor of Medicine
Faculty of Health Sciences
University of Cape Town
Cape Town, South Africa

Linda Gail-Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD: consultant/advisor/speaker: Gilead, Janssen, Johnson & Johnson, Merck, ViiV.